Toshiyuki Sumi

2PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 01, 2025
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial.

Shin Nishio, Tadaaki Nishikawa, Masahiko Mori

|Oct 20, 2020
The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG.

Eiji Kondo, Tsutomu Tabata, Nao Suzuki

Pageof 1

Frequent Collaborators

2 joint publications

Eiji Kondo

2 joint publications

Aikou Okamoto

1 joint publications

Tsutomu Tabata

1 joint publications

Nao Suzuki